NCT01372085View on ClinicalTrials.gov

Single Dose Study in Healthy Participants to Investigate the Safety and Absorption of LY2584702

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Healthy Participants
Interventions
DRUG

LY2584702 Reference Formulation

Administered orally

DRUG

LY2584702 Test Formulation

Administered orally

DRUG

Placebo

Administered orally

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Singapore

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01372085 - Single Dose Study in Healthy Participants to Investigate the Safety and Absorption of LY2584702 | Biotech Hunter | Biotech Hunter